Salix Pharmaceuticals Ltd.
1700 Perimeter Park Drive
Morrisville,
NC 27560-8404
United States - Map
Phone: 919-862-1000
Fax: 919-862-1095
Web Site: http://www.salix.com
| Salix Pharmaceuticals, Ltd., a specialty pharmaceutical company, engages in acquiring, developing, and commercializing prescription drugs used in the treatment of gastrointestinal disorders in the United States. Its products include Xifaxan tablet, a gastrointestinal-specific oral antibiotic for the treatment of patients with travelers’ diarrhea; MoviPrep, a liquid polyethylene glycol-salt bowel cleansing product; Visicol and OsmoPrep tablets for cleansing of the colon as a preparation for colonoscopy in adults; and Azasan, a drug that suppresses immune system responses and is indicated for preventing rejection of kidney transplants and treatment of severe arthritis. The company also offers Anusol-HC and Proctocort, the hydrocortisone creams and suppositories for use in inflamed hemorrhoids and postirradiation proctitis, as well as an adjunct in the treatment of chronic ulcerative colitis and inflammatory conditions; Pepcid and Diuril oral suspensions, which are used for gastrointestinal indications that include the treatment of duodenal ulcer, benign gastric ulcer, and gastro esophageal reflux diseases; Apriso, for the maintenance of remission of ulcerative colitis in adults; and Colazal capsules for the treatment of ulcerative colitis. Salix Pharmaceuticals’ products under development include Balsalazide Disodium tablets for ulcerative colitis; Crofelemer for HIV-associated diarrhea; Vapreotide acetate for acute esophageal variceal bleeding; and Metoclopramide-Zydis for the treatment of gastroesphageal reflux and gastroparesis. It has collaboration agreements with aaiPharma LLC; Alfa Wassermann S.P.A.; Biorex Laboratories Limited; Cedars—Sinai Medical Center; ALW Partnership; Debiopharm Group; Dr. Falk Pharma GmbH; King Pharmaceuticals, Inc.; Merck & Co., Inc.; Napo Pharmaceuticals, Inc.; Norgine B.V.; and Wilmington Pharmaceuticals, LLC. The company was founded in 1989 and is headquartered in Morrisville, North Carolina. |
|
| Key Statistics |
| |
| | Pay | Exercised | Ms. Carolyn J. Logan , 60
Chief Exec. Officer, Pres |
$
1.03M |
$
0 | Mr. Adam C. Derbyshire , 43
Chief Financial Officer, Principal Accounting Officer and Exec. VP of Fin. & Admin. |
$
527.00K |
$
0 | Dr. William P. Forbes Pharm. D., 47
Chief Devel. Officer and Sr. VP of R&D |
$
455.00K |
$
0 | Mr. Stephen D. Celestini ,
Sec. |
N/A
| N/A | Mr. G. Michael Freeman ,
Associate VP of Investor Relations & Corp. Communications |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
1.14% Nasdaq 
Profile
